We are specialised in AI solutions for advanced therapies such as gene and cell therapies.
Location: France, Ile-de-France, Paris
Employees: 11-50
Total raised: $20M
Founded date: 2019
Investors 3
| Date | Name | Website |
| - | Aloe Priva... | aloe-group... |
| 11.02.2022 | Y Combinat... | ycombinato... |
| - | Debiopharm | debiopharm... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 13.09.2022 | Series A | $10M | - |
| 11.09.2022 | Seed | $10M | - |
Mentions in press and media 9
| Date | Title | Description |
| 16.01.2024 | WhiteLab Genomics and Siren Biotechnology Announce Partnership to Accelerate AI-Powered Advancements in Gene Therapy | PARIS, FRANCE, January 16, 2024 /EINPresswire.com/ -- WhiteLab Genomics, artificial intelligence (AI) leaders in genomic medicine, and Siren Biotechnology, the innovators of universal AAV immuno-gene therapy for cancer, today announced a st... |
| 10.11.2023 | Which Parisian Biotech Startups are Pioneering Industry Innovations in 2023? | Paris, the global hub for art, fashion, gastronomy, and culture is now extensively recognized for its astonishing progress in the Biotechnology industry. A new era of innovation and entrepreneurship is Growing in Ile-de-France, leading to a... |
| 27.09.2023 | VCoE and six start-ups nominated for Prix Galien | The Venture Centre of Excellence (VCoE), a public-private co-investment programme run by EIT Health and the European Investment Fund (EIF), has been nominated for a 2023 Prix Galien Award, which honours excellence in scientific innovation. ... |
| 19.09.2023 | Which Biotech Startups are Transforming Ile-de-France’s Industry Landscape in 2023? | Ile-de-France, a densely populated region encompassing the French capital, Paris, is also emerging as a hotbed of cutting-edge biotechnology startups. With French companies developing innovative solutions across fields like life sciences, g... |
| 14.09.2022 | Debiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence | Debiopharm Innovation Fund strategically invests in Whitelab Genomics' mission to make genomic medicine development faster and leaner for more efficient access to cancer patients in the future LAUSANNE, Switzerland, Sept. 14, 2022 /PRNewswi... |
| 13.09.2022 | Whitelab Genomics Raises $10M in Series A Funding | Whitelab Genomics, a Paris, France- and Cambridge (MA)-based developer of genomics medicines via technology powered by artificial intelligence (AI), raised 10m in Series A funding. Backers included Debiopharm Innovation Fund, the strategic ... |
| 12.09.2022 | How WhiteLab Genomics is using AI to aid gene and cell therapy development | French biotech company WhiteLab Genomics has raised $10 million in funding for an AI platform designed to aid the discovery and development of genomic therapies. Founded out of Paris in 2019, recent Y Combinator (YC) graduate WhiteLab Genom... |
| 30.03.2022 | Selected AI startups from YC’s Winter ’22 batch | Dozens of startups in Y Combinator’s Winter 2022 cohort do something that could be described as artificial intelligence. Though the term has lost much of its meaning, it’s still an important part of the tech landscape, and both using it and... |
| - | WhiteLab Genomics | “At WhiteLab Genomics we develop state of the art software solutions using AI in order to accelerate and de-risk gene and cell therapy developments.” |